Toshiba America Medical Systems
New Dose Reduction Technologies
This white paper details two applications which reduce radiation and contrast dose for some of the most common CT procedures and increase workflow by reducing numbers of exams.
Toshiba America Medical Systems
Contact Uswww.medical.toshiba.com
1-800-421-1968
View White Paper
Click here to download pdf
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.